| Product Code: ETC7914886 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Malaria Vaccine Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Malaria Vaccine Market - Industry Life Cycle |
3.4 Latvia Malaria Vaccine Market - Porter's Five Forces |
3.5 Latvia Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 Latvia Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Latvia Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of malaria prevention in Latvia |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Growing research and development activities in the field of malaria vaccines |
4.3 Market Restraints |
4.3.1 High costs associated with vaccine development and distribution |
4.3.2 Limited access to healthcare facilities in remote areas |
4.3.3 Regulatory challenges and approval processes for new vaccines |
5 Latvia Malaria Vaccine Market Trends |
6 Latvia Malaria Vaccine Market, By Types |
6.1 Latvia Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 Latvia Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 Latvia Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 Latvia Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 Latvia Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 Latvia Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 Latvia Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 Latvia Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Latvia Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 Latvia Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 Latvia Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 Latvia Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Latvia Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 Latvia Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 Latvia Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 Latvia Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Latvia Malaria Vaccine Market Import-Export Trade Statistics |
7.1 Latvia Malaria Vaccine Market Export to Major Countries |
7.2 Latvia Malaria Vaccine Market Imports from Major Countries |
8 Latvia Malaria Vaccine Market Key Performance Indicators |
8.1 Number of individuals vaccinated against malaria in Latvia |
8.2 Rate of adoption of malaria vaccination programs in the target population |
8.3 Investment in research and development for new and improved malaria vaccines |
9 Latvia Malaria Vaccine Market - Opportunity Assessment |
9.1 Latvia Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 Latvia Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Latvia Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Malaria Vaccine Market - Competitive Landscape |
10.1 Latvia Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Latvia Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here